TB-500 vs Thymalin

TB-500

TB-500 is the synthetic version of Thymosin Beta-4, a naturally occurring 43-amino acid peptide present in virtually all human and animal cells. Its primary mechanism of action centers on sequestering G-actin monomers, which promotes actin polymerization and cell migration essential for tissue repair. TB-500 also upregulates expression of laminin-5, a key component of the basement membrane, and activates Akt (protein kinase B) signaling, which research indicates promotes cell survival and inhibits apoptosis. Published studies have demonstrated TB-500's wound healing properties in dermal repair models (Malinda et al., Journal of Investigative Dermatology, 1999) and corneal epithelium regeneration. In equine research, Thymosin Beta-4 has been extensively studied for tendon and ligament repair, with published veterinary trials showing accelerated recovery timelines. The peptide's anti-inflammatory properties appear to operate through suppression of NF-kB and reduction of pro-inflammatory cytokines including IL-1beta and TNF-alpha. Compared to BPC-157, TB-500 has a broader tissue distribution and systemic migration capability, making it a preferred research compound for widespread inflammatory conditions rather than localized injury models. The two peptides target complementary repair mechanisms, which is why they are frequently combined in research studies. Store lyophilized powder at -20C; reconstitute with bacteriostatic water and refrigerate at 2-8C for up to 28 days. TB-500 is investigated by regenerative medicine centers, veterinary research institutions, and cardiology labs studying post-ischemic tissue recovery.

Thymalin

Thymalin is a polypeptide complex originally extracted from calf thymus glands, standardized as a mixture of short peptides including the dipeptide Glu-Trp (EW). Developed by Vladimir Khavinson and colleagues at the Saint Petersburg Institute of Bioregulation and Gerontology, Thymalin operates through thymic bioregulation, restoring T-cell populations and normalizing the ratio of T-helper to T-suppressor lymphocytes. It modulates thymulin production and supports immune homeostasis through gene expression changes in immunocompetent cells. Landmark cellular-aging research by Khavinson and Morozov published in Neuroendocrinology Letters reported that Thymalin use in a 6-year study of elderly subjects was associated with a 2-fold reduction in mortality rate compared to controls, alongside improvements in immune markers, endocrine function, and cardiovascular parameters. Additional studies published in Bulletin of Experimental Biology and Medicine showed restoration of melatonin production and normalization of cortisol rhythms in aged subjects receiving Thymalin. Research in animal models demonstrated increased average and maximum lifespan when Thymalin was used to aging rodents. Compared to Thymosin Alpha-1, which is a defined single-sequence peptide with extensive Western clinical data, Thymalin represents a complex bioregulatory approach rooted in the Russian peptide bioregulator tradition. Thymosin Alpha-1 has more targeted receptor-level data, while Thymalin's effects appear more systemic and multi-pathway. Both aim to restore immune competence, but through different pharmacological approaches. Lyophilized Thymalin should be stored at -20°C. Reconstitute with bacteriostatic water and store at 2-8°C, using within 3 weeks. Thymalin is primarily researched by gerontologists, immunologists studying age-related immune decline, and bioregulation scientists investigating peptide-based geroprotective interventions.

Frequently Asked Questions